Reported Reactions

Devices › Temporary carotid catheter for embolic capture

Device brand name · Temporary carotid catheter for embolic capture

Enroute Neuroprotection System: medical device reports filed with FDA

331 reports name it, 2019–2023. Manufacturer given most often on reports: Silk Road Medical. Product code NTE.

331
device reports naming the brand
0% of all MAUDE reports · about 46 a year
0
reports, 12 months to August 2026
0 in the 12 months before
0.3%
classified as malfunction
34.8% across the product code
0.6%
classified as death, as reported
2 reports · not verified by FDA

331 medical device reports received by FDA name the brand "Enroute Neuroprotection System" (temporary carotid catheter for embolic capture); the manufacturer given most often on reports is Silk Road Medical; received from April 2019 to April 2023. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.1%), death (0.6%) and malfunction (0.3%); across all temporary carotid catheter for embolic capture reports (product code NTE) death is recorded in 2.1% and malfunction in 34.8%. Event type is the reporter's classification of the report, not a verified outcome.

Reports by month, five years

0714Sep 2021: 10Oct 2021: 8Nov 2021: 12Dec 2021: 112022Jan 2022: 13Feb 2022: 5Mar 2022: 14Apr 2022: 7May 2022: 14Jun 2022: 11Jul 2022: 12Aug 2022: 10Sep 2022: 5Oct 2022: 4Nov 2022: 7Dec 2022: 82023Jan 2023: 3Feb 2023: 2Mar 2023: 4Apr 2023: 4May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0631262019: 620192020: 7620202021: 12620212022: 11020222023: 132023

Event type and report source

Event type, as classified on the report

Death0.6%2
Injury99.1%328
Malfunction0.3%1
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%331
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 5,335 reports carrying product code NTE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Device dislodged or dislocated10.3%1.1%
Insufficient device problem information10.3%0.9%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Vascular dissection22568%
Ischemia stroke4714.2%
Stroke/cva3711.2%
Brain injury3310%
Thrombosis/thrombus61.8%
Obstruction/occlusion30.9%
Extravasation20.6%
Infarction, cerebral20.6%
Transient ischemic attack20.6%
Atrial fibrillationan irregular heart rhythm10.3%
Convulsion/seizure10.3%
Deaththe patient died; cause not stated by this term10.3%
Embolism/embolus10.3%
Hemorrhagic stroke10.3%
Loss of range of motion10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureEnroute Neuroprotection SystemProduct code NTEAll MAUDE reports
Reports3315,33526,136,888
Share of that pool—6.2%0%
Classified as death, per 1,000 reports6219
Classified as injury99.1%62.7%36.2%
Classified as malfunction0.3%34.8%62.3%
Filed by the manufacturer100%98.1%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code NTE

BrandReportsLatest 12 monthsClassified as death
Emboshield Nav6 Embolic Protection System1,00401.7%
ENROUTE Transcarotid Neuroprotection System6601302%
Spider Fx649652%
Angioguard Rx367380.5%
Angioguard Rx Emboli Capture Guidewire System31700.6%
Angioguard Xp Emboli Capture Guidewire System27500%
Emboshield Nav6252900.8%
Spiderfx Embolic Protection Device23206%
Rx Accunet Embolic Protection System42902.1%
FilterWire EZ507710.4%
Filterwire Ez Emoblic Protection System16401.8%
Abbott26507.5%
Nanocross 0 14 Otw Pta Dilatation Catheter211220.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Enroute Neuroprotection System reports

How many FDA reports name Enroute Neuroprotection System?

331 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (99.1%), death (0.6%) and malfunction (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

device dislodged or dislocated (0.3%) and insufficient device problem information (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Enroute Neuroprotection System was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.